Atyr Pharma logo

Atyr Pharma Share Price (NASDAQ: ATYR)

$4.9

Live

Last updated on

Check the interactive Atyr Pharma Stock chart to analyse performance

Atyr Pharma stock performance

as on August 18, 2025 at 11:52 PM IST

  • Today's Low:$4.82
    Today's High:$5.01

    Day's Volatility :3.79%

  • 52 Weeks Low:$1.67
    52 Weeks High:$7.29

    52 Weeks Volatility :77.09%

Atyr Pharma Stock Returns

PeriodAtyr Pharma IncIndex (Russel 2000)
3 Months
42.44%
0.0%
6 Months
29.29%
0.0%
1 Year
159.26%
0.0%
3 Years
169.23%
-11.6%

Atyr Pharma Inc Key Stats

Check Atyr Pharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.9
Open
$4.93
Today's High
$5.01
Today's Low
$4.82
Market Capitalization
$549.7M
Today's Volume
$4.3M
52 Week High
$7.2904
52 Week Low
$1.67
Revenue TTM
$0.0
EBITDA
$-69.4M
Earnings Per Share (EPS)
$-0.79
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-85.39%

Stock Returns calculator for Atyr Pharma Stock including INR - Dollar returns

The Atyr Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atyr Pharma investment value today

Current value as on today

₹2,63,333

Returns

₹1,63,333

(+163.33%)

Returns from Atyr Pharma Stock

₹1,59,259 (+159.26%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Atyr Pharma Stock

190.0%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Investment in Atyr Pharma Shares from India has grown by 190.0% over the past 30 days, indicating increased transactional activity.

120%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Atyr Pharma Stock from India on INDmoney has increased by 120% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Atyr Pharma Stock

Rating
Trend

Atyr Pharma Share Price Target

What analysts predicted

Upside of 294.9%

Target:

$19.35

Current:

$4.90

Atyr Pharma share price target is $19.35, a slight Upside of 294.9% compared to current price of $4.90 as per analysts' prediction.

Atyr Pharma Stock Insights

  • Price Movement

    In the last 7 days, ATYR stock has moved down by -12.7%

Atyr Pharma Technicals Summary

Sell

Neutral

Buy

Atyr Pharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Atyr Pharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Atyr Pharma Inc logo
-14.19%
29.29%
159.26%
169.23%
169.23%
Regeneron Pharmaceuticals, Inc. logo
6.39%
-14.65%
-51.51%
-6.14%
-7.82%
Beone Medicines Ltd logo
10.08%
34.96%
66.94%
83.8%
36.85%
Vertex Pharmaceuticals Incorporated logo
-14.33%
-15.0%
-19.52%
31.35%
45.44%
Alnylam Pharmaceuticals, Inc. logo
40.06%
79.56%
63.55%
107.86%
227.15%

About Atyr Pharma Inc

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Organization
Atyr Pharma
Employees
56
CEO
Dr. Sanjay S. Shukla M.D., M.S.
Industry
Miscellaneous

Key Management of Atyr Pharma Inc

NameTitle
Dr. Sanjay S. Shukla M.D., M.S.
President, CEO & Director
Ms. Nancy E. Denyes Krueger J.D.
General Counsel & Corporate Secretary
Dr. Jayant Aphale MBA, Ph.D.
Vice President of Technical Operations
Ms. Ashlee Dunston
Director of Investor Relations & Corporate Communications
Mr. Peter Villiger
Vice President of Corporate Development
Ms. Danielle Campbell
VP of Human Resource
Ms. Dalia R. Rayes M.B.A.
Head of Commercial, Global Efzofitimod Franchise
Dr. Leslie Nangle Ph.D.
Vice President of Research

Important FAQs about investing in ATYR Stock from India :

What is Atyr Pharma share price today?

Atyr Pharma share price today is $4.90 as on . Atyr Pharma share today touched a day high of $5.01 and a low of $4.82.

What is the 52 week high and 52 week low for Atyr Pharma share?

Atyr Pharma share touched a 52 week high of $7.29 and a 52 week low of $1.67. Atyr Pharma stock price today, is trending at $4.90, lower by 32.79% versus the 52 week high.

How to invest in Atyr Pharma Stock (ATYR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Atyr Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atyr Pharma Shares that will get you 0.3061 shares as per Atyr Pharma share price of $4.90 per share as on August 18, 2025 at 11:52 PM IST.

What is the minimum amount required to buy Atyr Pharma Stock (ATYR) from India?

Indian investors can start investing in Atyr Pharma (ATYR) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Atyr Pharma stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Atyr Pharma share’s latest price of $4.90 as on August 18, 2025 at 11:52 PM IST, you will get 2.0408 shares of Atyr Pharma. Learn more about fractional shares .

What are the returns that Atyr Pharma has given to Indian investors in the last 5 years?

Atyr Pharma stock has given 169.23% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?